# Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans

> **NCT00871325** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tsumura USA** · enrollment: 60 (actual)

## Conditions studied

- Postoperative Ileus

## Interventions

- **DRUG:** Daikenchuto (TU-100)
- **DRUG:** Daikenchuto (TU-100)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00871325
- **Lead sponsor:** Tsumura USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-12
- **Final completion:** 2010-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00871325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00871325, "Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00871325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*